Navilas 577s
Commercial- Indications
- Diabetic macular edema, Proliferative diabetic retinopathy, Retinal vein occlusions
Company intelligence / Profile preview
OD-OS is a German medical device company specializing in advanced navigated laser systems for the treatment of retinal diseases. Its flagship product, Navilas®, is a digital imaging-guided laser platform that enables precise and efficient focal/grid and panretinal photocoagulation. The system has been adopted worldwide for treating diabetic macular edema, proliferative diabetic retinopathy, branch/central retinal vein occlusion, and other conditions requiring targeted or panretinal photocoagulation. Clinical studies have demonstrated improved accuracy, reduced pain compared to conventional lasers, shorter procedure times, and enhanced documentation capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OD-OS.